The Japanese Journal of Antibiotics
Online ISSN : 2186-5477
Print ISSN : 0368-2781
ISSN-L : 0368-2781
Volume 53, Issue 9
Displaying 1-3 of 3 articles from this issue
  • MATSUHISA INOUE, AKIO KUGA, SATORU KAIEDA, MIYUKI HOSAKA, HIDERO KITAS ...
    2000 Volume 53 Issue 9 Pages 593-608
    Published: September 25, 2000
    Released on J-STAGE: May 17, 2013
    JOURNAL FREE ACCESS
    In vitro drug sensitivity of clinically isolated bacteria against prulifloxacin (PUFX), which is a new quinolone, was investigated, and the antibacterial activity and susceptibility rate at clinical breakpoint were compared with those of norfloxacin, ofloxacin (OFLX), ciprofloxacin, tosufloxacin, fleroxacin, sparfloxacin and levofloxacin (LVFX).
    The following results were obtained.
    1) PUFX showed a broad-spectrum antibacterial activity against both Gram-positive and Gram-negative bacteria.
    2) MIC80 of PUFX was 0.25 and 1μg/ml, against methicillin susceptible Staphylococcus aureus and Streptococcus. pneumoniae, respectively and below 0.125μg/ml against Gram-negative Enterobacteriaceae. MIC90 of PUFX against Pseudomonas aeruginosa, which has MIC not exceeding 4μg/ml to OFLX, was 0.5μg/ml.
    3) PUFX was judged as active against the bacteria under the criteria proposed presented by “the Sensitivity Determination Committee for Antibiotics, Japan Society of Chemotherapy: Break Point for Respiratory Infectious Diseases and Sepsis”. It is suggested that the sensitivity of each bacterial species to PUFX was high.
    4) From the correlation analysis of MIC, PUFX was shown to have two to eight times higher antibacterial activity than LVFX for Citrobacter freundii, Serratia marcescens and Pseudomonas aeruginosa.
    5) PUFX showed potent short-time bactericidal activity against S. aureus and P. aeruginosa.
    Download PDF (1532K)
  • YOZO SHIBATA, KOJI MIDORIKAWA, MASATOSHI NAITO, MOTOKI YATSUNAMI, KENJ ...
    2000 Volume 53 Issue 9 Pages 609-613
    Published: September 25, 2000
    Released on J-STAGE: May 17, 2013
    JOURNAL FREE ACCESS
    Fifteen patients who were performed a rotator cuff repair were subjected for the determination of a concentration of isepamicin sulfate (ISP), which was infused intravenously, in venous blood and bone marrow blood. The concentrations were measured at 0, 30, 60 minutes after the injection. There was no statistically significance between ISP concentrations in venous and bone marrow blood. This study revealed that the transference of ISP to the bone marrow was excellent.
    Download PDF (551K)
  • 2000 Volume 53 Issue 9 Pages C4-
    Published: 2000
    Released on J-STAGE: May 17, 2013
    JOURNAL FREE ACCESS
feedback
Top